In Vivo Measurements of Glutamate, GABA, and NAAG in Schizophrenia

Coyle, 2004, The GABA-glutamate connection in schizophrenia: which is the proximate cause?, Biochem Pharmacol, 68, 1507, 10.1016/j.bcp.2004.07.034

Lewis, 2005, Cortical inhibitory neurons and schizophrenia, Nat Rev Neurosci, 6, 312, 10.1038/nrn1648

Konradi, 2003, Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment, Pharmacol Ther, 97, 153, 10.1016/S0163-7258(02)00328-5

Holcomb, 2004, Cognitive dysfunction in schizophrenia: glutamatergic hypoactivity and dopaminergic failure, Drug Discov Today: Dis Mech, 1, 435, 10.1016/j.ddmec.2004.11.017

Benes, 2001, GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder, Neuropsychopharmacology, 25, 1, 10.1016/S0893-133X(01)00225-1

Nudmamud, 2003, N-acetylaspartate and N-acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study, Biol Psychiatry, 53, 1138, 10.1016/S0006-3223(02)01742-0

Reynolds, 2005, Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain, Schizophr Res, 73, 147, 10.1016/j.schres.2004.02.003

Tsai, 1995, Abnormal excitatory neurotransmitter metabolism in schizophrenic brains, Arch Gen Psychiatry, 52, 829, 10.1001/archpsyc.1995.03950220039008

Stone, 2009, Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia, Curr Pharm Des, 15, 2594, 10.2174/138161209788957438

Marsman, Glutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studies [published online ahead of print July 11, 2011], Schizophr Bull

Mescher, 1998, Simultaneous in vivo spectral editing and water suppression, NMR Biomed, 11, 266, 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J

Ongür, 2010, Elevated gamma-aminobutyric acid levels in chronic schizophrenia, Biol Psychiatry, 68, 667, 10.1016/j.biopsych.2010.05.016

Kegeles, 2012, Elevated prefrontal cortex gamma-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy, Arch Gen Psychiatry, 69, 449, 10.1001/archgenpsychiatry.2011.1519

Yoon, 2010, GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression, J Neurosci, 30, 3777, 10.1523/JNEUROSCI.6158-09.2010

Goto, 2009, Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study, Schizophr Res, 112, 192, 10.1016/j.schres.2009.04.026

Tayoshi, 2010, GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study, Schizophr Res, 117, 83, 10.1016/j.schres.2009.11.011

Jessen, N-acety laspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia, Schizophr Bull

Fornito, 2009, Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology, Schizophr Bull, 35, 973, 10.1093/schbul/sbn025

Rowland, 2009, A review of diffusion tensor imaging in schizophrenia, Clinl Schizophr Relat Psychos, 3, 142, 10.3371/CSRP.3.3.3

Lieberman, 1999, Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective, Biol Psychiatry, 46, 729, 10.1016/S0006-3223(99)00147-X

Bustillo, 2011, Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla, Biol Psychiatry, 69, 19, 10.1016/j.biopsych.2010.08.024

Montelius, 2009, Foressell-Aronsson. Matlab tool for segmentation and re-creation of MRS volumes of interst in MRI image stacks, Proc Eur Soc Mag Resonan Med Biol 2009 Congr, 320

Provencher, 2001, Automatic quantitation of localized in vivo 1H spectra with LCModel, NMR Biomed, 14, 260, 10.1002/nbm.698

Zhong, 2004, Localized in vivo human 1H MRS at very short echo times, Magn Reson Med, 52, 898, 10.1002/mrm.20201

Tkác, 2001, In vivo 1H NMR spectroscopy of the human brain at 7 T, Magn Reson Med, 46, 451, 10.1002/mrm.1213

Mullins, 2008, Comparative reliability of proton spectroscopy techniques designed to improve detection of J-coupled metabolites, Magn Reson Med, 60, 964, 10.1002/mrm.21696

O’Gorman, 2011, In vivo detection of GABA and glutamate with MEGA-PRESS: reproducibility and gender effects, J Magn Reson Imaging, 33, 1262, 10.1002/jmri.22520

Hasler, 2007, Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy, Arch Gen Psychiatry, 64, 193, 10.1001/archpsyc.64.2.193

Edden, 2007, In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla, Magn Reson Med, 57, 977, 10.1002/mrm.21234

Soher, 1996, Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference, Magn Reson Med, 36, 335, 10.1002/mrm.1910360302

Tayoshi, 2009, Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS), Schizophr Res, 108, 69, 10.1016/j.schres.2008.11.014

Théberge, 2003, Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS, Am J Psychiatry, 160, 2231, 10.1176/appi.ajp.160.12.2231

Bustillo, 2010, 1H-MRS at 4 tesla in minimally treated early schizophrenia, Mol Psychiatry, 15, 629, 10.1038/mp.2009.121

Théberge, 2002, Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers, Am J Psychiatry, 159, 1944, 10.1176/appi.ajp.159.11.1944

de la Fuente-Sandoval, 2011, Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis, Neuropsychopharmacology, 36, 1781, 10.1038/npp.2011.65

Ongür, 2008, Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania, Biol Psychiatry, 64, 718, 10.1016/j.biopsych.2008.05.014

Tibbo, 2004, 3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia, Am J Psychiatry, 161, 1116, 10.1176/appi.ajp.161.6.1116

Olney, 1995, Glutamate receptor dysfunction and schizophrenia, Arch Gen Psychiatry, 52, 998, 10.1001/archpsyc.1995.03950240016004

Hulshoff Pol, 2008, What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia, Schizophr Bull, 34, 354, 10.1093/schbul/sbm168

Glantz, 2000, Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia, Arch Gen Psychiatry, 57, 65, 10.1001/archpsyc.57.1.65

Lutkenhoff, 2010, Proton MRS in twin pairs discordant for schizophrenia, Mol Psychiatry, 15, 308, 10.1038/mp.2008.87

Amitai, 2012, Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats, Neuropharmacology, 62, 1422, 10.1016/j.neuropharm.2011.01.008

Bustillo, 2005, Hypometabolic Medial-Frontal Effects of Chronic Intermitent PCP Exposure in Rats Assessed with High Resolution Magic Angle Spin 11.7T Proton Magnetic Resonance Spectroscopy

Gonzalez-Burgos, 2010, Alterations of cortical GABA neurons and network oscillations in schizophrenia, Curr Psychiatry Rep, 12, 335, 10.1007/s11920-010-0124-8

Gandal, 2012, Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia, Neuropharmacology, 62, 1504, 10.1016/j.neuropharm.2011.02.007

Uhlhaas, 2010, Abnormal neural oscillations and synchrony in schizophrenia, Nat Rev Neurosci, 11, 100, 10.1038/nrn2774

Gaetz, 2011, Relating MEG measured motor cortical oscillations to resting gamma-aminobutyric acid (GABA) concentration, Neuroimage, 55, 616, 10.1016/j.neuroimage.2010.12.077

Muthukumaraswamy, 2009, Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans, Proc Natl Acad Sci USA, 106, 8356, 10.1073/pnas.0900728106

Kegeles, 2011, Frontal cortex GABA, oscillations, and working memory in schizophrenia, Schizophr Bull, 37

Baltan, 2009, Ischemic injury to white matter: an age-dependent process, Neuroscientist, 15, 126, 10.1177/1073858408324788

Olszewski, 2004, NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR, J Neurochem, 89, 876, 10.1111/j.1471-4159.2004.02358.x

Krystal, 2005, Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects, Psychopharmacology (Berl), 179, 303, 10.1007/s00213-004-1982-8

Cartmell, 1999, The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus D-amphetamine motor behaviors in rats, J Pharmacol Exp Ther, 291, 161

Homayoun, 2005, Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats, J Neurophysiol, 93, 1989, 10.1152/jn.00875.2004

Patil, 2007, Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial, Nat Med, 13, 1102, 10.1038/nm1632